A Win For CNS Pharmaceuticals, Inc.
Wed, Jan 05, 2022 at 05:30 PM
CNS Pharmaceuticals, Inc. (CNSP:NASDAQ) shot up at $1.05, representing a gain of 31.4%. The stock appeared on our News Catalysts scanner on Fri, Dec 31, 2021 at 05:43 PM in the 'BIOTECH' category. From Tue, Dec 21, 2021, the stock recorded 33.33% Up Days and 20.00% Green Days
About CNS Pharmaceuticals, Inc. (CNSP:NASDAQ)
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
Top 10 Gainers:
- MYNZ (MYNZ:NASDAQ), 47.38%
- ELYM (ELYM:NASDAQ), 38.28%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 31.36%
- EVTL (EVTL:NYSE), 29.1%
- Castlight Health, Inc. (CSLT:NYSE), 23.78%
- EWTX (EWTX:NASDAQ), 22.47%
- Comstock Mining Inc. (LODE:NYSEMKT), 13.08%
- XOMA Corporation (XOMA:NASDAQ), 12.69%
- Insignia Systems, Inc. (ISIG:NASDAQ), 12.47%
- Nuverra Environmental Solutions, Inc. (NES:NYSEMKT), 11.67%